Candesartan Cilexetil And Hydrochlorothiazide Tablet
Product Images NDC 62559-660

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil And Hydrochlorothiazide (NDC 62559-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Candesartan Cilexetil (Image 01)

Chemical structure diagram of the active ingredient Candesartan Cilexetil. The diagram includes a labeled site of ester hydrolysis, showing the molecular arrangement with rings and functional groups.*

FDA Label Image

Chemical Structure For Hydrochlorothiazide (Image 02)

Chemical structure diagram of Candesartan Cilexetil and Hydrochlorothiazide active ingredient, showing molecular bonds and functional groups characteristic of the compound.*

FDA Label Image

Image 03

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets USP 16 mg/12.5 mg, oral tablets. Contains 90 tablets. Manufactured by AstraZeneca AB, Sweden, and distributed by ANI Pharmaceuticals, Inc., Minnesota. Includes NDC 62559-660-90, barcode, and storage instructions at 20 to 25°C. Rx only.*

FDA Label Image

Image 04

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets USP, 32 mg/12.5 mg, showing tablet count of 90. Manufactured by AstraZeneca in Sweden and distributed by ANI Pharmaceuticals, Inc. The label includes storage instructions, dosage advisory, barcode, and product identification numbers.*

FDA Label Image

Image 05

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets USP 32 mg/25 mg, oral tablet dosage form. The label states each tablet contains 32 mg of Candesartan Cilexetil and 25 mg of Hydrochlorothiazide. The product is manufactured by AstraZeneca AB, Sweden and distributed by ANI Pharmaceuticals, Inc. The label indicates the package contains 90 tablets and is for prescription use only.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.